LUCIRA HEALTH, INC. (a Delaware corporation) [●] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2021 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 1st, 2021 Company Industry Jurisdiction
LUCIRA HEALTH, INC. STOCK OPTION AGREEMENTStock Option Agreement • February 1st, 2021 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 1st, 2021 Company IndustryAs reflected by your Stock Option Grant Notice (“Grant Notice”) Lucira Health, Inc. (the “Company”) has granted you an option under its 2021 Equity Incentive Plan (the “Plan”) to purchase a number of shares of Common Stock at the exercise price indicated in your Grant Notice (the “Option”). Capitalized terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan shall have the meanings set forth in the Grant Notice or Plan, as applicable. The terms of your Option as specified in the Grant Notice and this Stock Option Agreement constitute your Option Agreement.
LUCIRA HEALTH, INC.Employment Agreement • February 1st, 2021 • Lucira Health, Inc. • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 1st, 2021 Company Industry JurisdictionOn behalf of LUCIRA HEALTH, INC. (the “Company”), it is my pleasure to offer you the position of Chief Operating Officer. The terms of your new employment are set forth below in this employment agreement (the “Agreement”).